Category: Stem Cell
Stem Cell market research reports by Frost & Sullivan
-
CGT Research Outlook and Technology Growth Opportunities
CGT Research Outlook and Technology Growth Opportunities CGT Landscape Assessment The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and ... Read More
-
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases ... Read More
-
Therapeutic Advances in Amyloidosis
Therapeutic Advances in Amyloidosis Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, ... Read More
Research Assistance
